Pricing Log in Create free account
Saturday 17 October 2026 Export ABBV’s income statement to Excel — free account

AbbVie Inc.

ABBV Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 290.4%, free cash flow fell 36.2% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

285.42 2.02 +0.71%
Market cap
$500.8B
P/E
80.6×
Fwd P/E
27.8×
Dividend yield
2.42%
F-score
8/9
Altman Z
2.31
Beneish M
−2.86
Dividend safety
44/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

AbbVie Inc. (ABBV) P/B ratio

Alert me on P/B ratio

AbbVie Inc. has no meaningful P/B ratio: its trailing twelve-month book value is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 253× (March 2025) — the current reading is the lowest in ten years.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 0.0× —
FY2024 93.4× 243.84%
FY2023 27.2× 63.37%
FY2022 16.6× 7.15%
FY2021 15.5× 13.84%
FY2020 13.6× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 30.8× 41.12%
FY2016 21.8× (10.52%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 253×
Ten-year median 17.0×
Current reading's percentile 28

P/B ratio against peers

Company P/B ratio
ABBV AbbVie Inc. n/m
PFE Pfizer Inc. compare 2.0×
AZN AstraZeneca PLC compare 5.1×
NVS Novartis AG compare 6.8×
JNJ Johnson & Johnson compare 7.2×
MRK Merck & Co., Inc. compare 8.6×
GILD Gilead Sciences, Inc. compare 16.5×
AMGN Amgen Inc. compare 20.0×
LLY Eli Lilly and Company compare 33.1×
Drug Manufacturers General industry median 5.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on ABBV